Diabetes Care Devices - United Arab Emirates

Revenue in the Diabetes Care Devices market market in the United Arab Emirates is anticipated to reach US$70.09m in 2024.
The revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 14.61%, leading to a market volume of US$138.60m by 2029.
In a global context, the highest revenue will be generated the United States, with an expected figure of US$11.71bn in 2024.
The United Arab Emirates is witnessing a significant shift towards advanced diabetes care devices, driven by increasing health awareness and digital health innovations.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in the United Arab Emirates is witnessing substantial growth, fueled by factors such as increased prevalence of diabetes, rising health awareness, and advancements in technology that enhance patient management and monitoring solutions.

Customer preferences: Consumers in the United Arab Emirates are increasingly prioritizing personalized diabetes management solutions, reflecting a cultural shift towards proactive health care. There is a growing demand for advanced glucose monitoring devices, including continuous glucose monitors (CGMs) and smart insulin pens, as users seek more accurate and convenient ways to track their blood sugar levels. Additionally, the rise of telehealth services is enabling patients to access specialized diabetes care remotely, accommodating the fast-paced lifestyle of urban populations while ensuring continuous support and education.

Trends in the market: In the United Arab Emirates, the Diabetes Care Devices Market is experiencing a surge in demand for innovative glucose monitoring solutions, particularly continuous glucose monitors (CGMs) and smart insulin pens. This trend reflects a significant shift towards personalized diabetes management, as patients seek more precise and user-friendly methods for tracking their blood sugar levels. The integration of telehealth services is further enhancing patient engagement, enabling remote access to specialized diabetes care. For industry stakeholders, these developments present substantial opportunities to enhance product offerings and expand market reach, ultimately contributing to improved patient outcomes.

Local special circumstances: In the United Arab Emirates, the Diabetes Care Devices Market is influenced by a blend of cultural attitudes towards health and wellness, as well as regulatory frameworks promoting innovative medical technologies. The UAE's high prevalence of diabetes, driven by lifestyle factors and an increasing prevalence of obesity, has heightened awareness and demand for effective management devices like continuous glucose monitors and smart insulin pens. Additionally, government initiatives focused on improving healthcare access and promoting smart health technologies foster a conducive environment for industry growth, encouraging investments in advanced diabetes care solutions.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the United Arab Emirates is significantly shaped by macroeconomic factors, including national economic health, investment in healthcare infrastructure, and global economic trends. The UAE's robust economy, bolstered by diversification efforts away from oil dependency, allows for increased funding in healthcare innovations. Favorable fiscal policies and governmental support for healthcare initiatives enhance accessibility to advanced diabetes management technologies. Furthermore, the rising prevalence of diabetes, coupled with global trends towards preventive healthcare, drives the demand for sophisticated devices, fostering a vibrant market environment.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.